ContextVision Webcast Q4 2015 Follow the link: http://webbtv.nu/contextvisionQ42015/ to find the Q4 webcast by CEO Anita Tollstadius The best year in our history ContextVision, the leading provider of image processing software, has delivered a record-breaking year. Reaching the highest yearly revenues ever and topped off by very good R&D-results within artificial intelligence and deep learning. […]

ContextVision Webcast Q3 2015 Follow the link: http://webbtv.nu/contextvisionq32015/ to find the Q3 webcast by CEO Anita Tollstadius Strong third quarter for ContextVision ContextVision AB (OSE: COV), the medical imaging software company, today announced its third quarter 2015 financial results. ContextVision achieved one of its best quarterly financial results ever, despite expanded R&D activity. ContextVision’s cash […]

ContextVision continues positive sales development ContextVision AB (OSE: COV), the medical imaging software company, today announced its second quarter and first half 2015 financial results. ContextVision continues its positive sales development. Revenues in the second quarter were 15 per cent higher than in the corresponding quarter last year and at par with the strong first […]

Sales growth and improved margins for ContextVision ContextVision AB (OSE: COV), the medical imaging software company, today announced its first quarter 2015 results. The Company’s had its best quarter in more than two years in terms of sales, and the operating margin bounced back into double digits after a relatively weak fourth quarter. ContextVision’s sales […]

Sales growth and increased R&D efforts ContextVision AB (OSE: COV), the medical imaging software company, today announced its fourth quarter and full year 2014 financial results. The Company saw sales growth both in the fourth quarter and for the full year, while the results were affected by increased research and development activities. For the full […]

ContextVision continued its stable sales development in the third quarter 2014 and saw a five per cent sales growth after the first nine months. The Company reached several milestones in broadening its technology and product offering....

Q2 HIGHLIGHTS Further positive sales development New major long term ultrasound customer signed All cases in long lasting legal dispute finally closed...

Q1 HIGHLIGHTS Strong first quarter sales, Acquisition of unique 3D rendering technology, Milestone for new technology platform reached...

Q4 HIGHLIGHTS Governmental grant for new pilot research project, in line with growth strategy. New Mammo 2 product successfully launched at RSNA. New product configuration for Ultrasound Point-of-Care...

Q3 HIGHLIGHTS Broadened Ultrasound product portfolio, Strengthened sales efforts in Russia, New academic collaboration in order to broaden offer for 3D Ultrasound...